Search results
Results from the WOW.Com Content Network
Marketing authorisation. Marketing authorisation is the process of reviewing and assessing the evidence to support a medicinal product, such as a drug, in relation to its marketing, finalised by granting of a licence to be sold. This process is performed within a legal framework defining the requirements necessary for successful application to ...
Digital object identifier. A digital object identifier (DOI) is a persistent identifier or handle used to uniquely identify various objects, standardized by the International Organization for Standardization (ISO). [1] DOIs are an implementation of the Handle System; [2][3] they also fit within the URI system (Uniform Resource Identifier).
WP:DOI. A digital object identifier (DOI) is a unique persistent identifier to a published work, similar in concept to an ISBN. Wikipedia supports the use of DOI to link to published content. Where a journal source has a DOI, it is good practice to use it, in the same way as it is good practice to use ISBN references for book sources.
Government of Massachusetts. The Commonwealth of Massachusetts is governed by a set of political tenets laid down in its state constitution. Legislative power is held by the bicameral General Court, which is composed of the Senate and House of Representatives. The governor exercises executive power with other independently elected officers: the ...
v. t. e. An Abbreviated New Drug Application (ANDA) is an application for a U.S. generic drug approval for an existing licensed medication or approved drug. The ANDA is submitted to FDA's Center for Drug Evaluation and Research, Office of Generic Drugs, which provides for the review and ultimate approval of a generic drug product.
Massachusetts Public Records Law is a law in Massachusetts detailing what kinds of documents are actually public records. [1] It is a state law that is similar to the federal Freedom of Information Act, which was signed into law by Lyndon B. Johnson in 1966. [2] According to the Boston Globe newspaper in 2016, "Massachusetts is currently the ...
[6] [1] [5] The immediate-release form has an elimination half-life of 2.5 hours [6] [2] while the half-life of the extended-release form is 7 hours. [1] Viloxazine was first described by 1972 [10] and was marketed as an antidepressant in Europe in 1974. [6] [11] It was not marketed in the United States at this time. [12]
v. t. e. The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency (EMEA). [4][5] The EMA was set up in 1995, with funding ...